These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36629356)

  • 21. Detection of Four Distinct Volatile Indicators of Colorectal Cancer using Functionalized Titania Nanotubular Arrays.
    Bhattacharyya D; Kumar P; Mohanty SK; Smith YR; Misra M
    Sensors (Basel); 2017 Aug; 17(8):. PubMed ID: 28777343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Volatile organic compounds emitted from faeces as a biomarker for colorectal cancer.
    Bond A; Greenwood R; Lewis S; Corfe B; Sarkar S; O'Toole P; Rooney P; Burkitt M; Hold G; Probert C
    Aliment Pharmacol Ther; 2019 Apr; 49(8):1005-1012. PubMed ID: 30828825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detecting cancer by breath volatile organic compound analysis: a review of array-based sensors.
    Queralto N; Berliner AN; Goldsmith B; Martino R; Rhodes P; Lim SH
    J Breath Res; 2014 Jun; 8(2):027112. PubMed ID: 24862241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of colorectal cancer (CRC) by urinary volatile organic compound analysis.
    Arasaradnam RP; McFarlane MJ; Ryan-Fisher C; Westenbrink E; Hodges P; Thomas MG; Chambers S; O'Connell N; Bailey C; Harmston C; Nwokolo CU; Bardhan KD; Covington JA
    PLoS One; 2014; 9(9):e108750. PubMed ID: 25268885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative analysis of volatile organic compounds of breath and urine for distinguishing patients with liver cirrhosis from healthy controls by using electronic nose and voltammetric electronic tongue.
    Zaim O; Diouf A; El Bari N; Lagdali N; Benelbarhdadi I; Ajana FZ; Llobet E; Bouchikhi B
    Anal Chim Acta; 2021 Nov; 1184():339028. PubMed ID: 34625262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic performance of volatile organic compounds analysis and electronic noses for detecting colorectal cancer: a systematic review and meta-analysis.
    Wang Q; Fang Y; Tan S; Li Z; Zheng R; Ren Y; Jiang Y; Huang X
    Front Oncol; 2024; 14():1397259. PubMed ID: 38817891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colorectal cancer screening with odour material by canine scent detection.
    Sonoda H; Kohnoe S; Yamazato T; Satoh Y; Morizono G; Shikata K; Morita M; Watanabe A; Morita M; Kakeji Y; Inoue F; Maehara Y
    Gut; 2011 Jun; 60(6):814-9. PubMed ID: 21282130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The potential of volatile organic compounds-based breath analysis for COVID-19 screening: a systematic review & meta-analysis.
    Subali AD; Wiyono L; Yusuf M; Zaky MFA
    Diagn Microbiol Infect Dis; 2022 Feb; 102(2):115589. PubMed ID: 34879323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study.
    Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I
    J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensors for breath testing: from nanomaterials to comprehensive disease detection.
    Konvalina G; Haick H
    Acc Chem Res; 2014 Jan; 47(1):66-76. PubMed ID: 23926883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noninvasive detection of colorectal cancer by analysis of exhaled breath.
    Wang C; Ke C; Wang X; Chi C; Guo L; Luo S; Guo Z; Xu G; Zhang F; Li E
    Anal Bioanal Chem; 2014 Jul; 406(19):4757-63. PubMed ID: 24820062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemiresistive Sensor Array with Nanostructured Interfaces for Detection of Human Breaths with Simulated Lung Cancer Breath VOCs.
    Shang G; Dinh D; Mercer T; Yan S; Wang S; Malaei B; Luo J; Lu S; Zhong CJ
    ACS Sens; 2023 Mar; 8(3):1328-1338. PubMed ID: 36883832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exhaled-breath Testing for Prostate Cancer Based on Volatile Organic Compound Profiling Using an Electronic Nose Device (Aeonose™): A Preliminary Report.
    Waltman CG; Marcelissen TAT; van Roermund JGH
    Eur Urol Focus; 2020 Nov; 6(6):1220-1225. PubMed ID: 30482583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid recognition of volatile organic compounds with colorimetric sensor arrays for lung cancer screening.
    Zhong X; Li D; Du W; Yan M; Wang Y; Huo D; Hou C
    Anal Bioanal Chem; 2018 Jun; 410(16):3671-3681. PubMed ID: 29654337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk stratification of symptomatic patients suspected of colorectal cancer using faecal and urinary markers.
    Widlak MM; Neal M; Daulton E; Thomas CL; Tomkins C; Singh B; Harmston C; Wicaksono A; Evans C; Smith S; Savage RS; Covington JA; Arasaradnam RP
    Colorectal Dis; 2018 Dec; 20(12):O335-O342. PubMed ID: 30248228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiation between genetic mutations of breast cancer by breath volatolomics.
    Barash O; Zhang W; Halpern JM; Hua QL; Pan YY; Kayal H; Khoury K; Liu H; Davies MP; Haick H
    Oncotarget; 2015 Dec; 6(42):44864-76. PubMed ID: 26540569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urine as a biological modality for colorectal cancer detection.
    Chandrapalan S; Arasaradnam RP
    Expert Rev Mol Diagn; 2020 May; 20(5):489-496. PubMed ID: 32130868
    [No Abstract]   [Full Text] [Related]  

  • 39. Urinary Volatile Organic Compound Testing in Fast-Track Patients with Suspected Colorectal Cancer.
    Boulind CE; Gould O; de Lacy Costello B; Allison J; White P; Ewings P; Wicaksono AN; Curtis NJ; Pullyblank A; Jayne D; Covington JA; Ratcliffe N; Turner C; Francis NK
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565258
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.